Research Use Only - Not for human consumption. 18+ only.
DGrade DTheoretical or in-vitro only; no meaningful independent human evidenceResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use onlyCosmetic & TopicalTopical

Melanostatin DM

A melanin synthesis inhibitor for skin brightening. Reduces hyperpigmentation with a gentle, long-term safety profile.

Beginner Basics

Plain-English guide to Melanostatin DM

What it does

This peptide slows down the production of melanin (the pigment that colors skin) by blocking an enzyme involved in that process. Researchers use it to study how to reduce dark spots and uneven skin tone over time.

Typical dose

A 1-3% concentration applied to skin once or twice daily; most people start at 1% to see how their skin responds before trying stronger concentrations.

When to inject

Applied during morning and/or evening skincare routines as a topical treatment (not injected).

Storage

Keep the dry powder in a dark, sealed container at -20°C (freezer temperature). Once mixed with liquid, store it in the refrigerator at 2-8°C in a dark container and use within 30 days; do not freeze the mixed version.

First-timer tip

Start with the weakest 1% concentration and use it for a week or two before increasing strength, so you can watch for any skin sensitivity or irritation.

Research Status

DGrade DTheoretical or in-vitro only; no meaningful independent human evidenceResearch OnlyResearch OnlyNo regulatory approval in any major jurisdiction; for research use only

Limited Clinical Data

For research purposes only. Not approved for human use. Not medical advice.

Research Areas

Reduces melanin production and hyperpigmentation
Brightens skin tone and evens complexion
Inhibits tyrosinase enzyme activity
Supports long-term skin lightening effects
Gentle alternative to harsh depigmenting agents

Side Effects

Mild skin irritation or erythema
UncommonMild

May occur with initial application or in sensitive individuals. Usually resolves within 1-2 weeks of continued use. Reduce frequency to 1x daily if irritation persists.

Dryness or tightness
UncommonMild

Topical peptides can occasionally cause mild dryness. Use a hydrating moisturizer after application. Ensure adequate hydration.

Contact dermatitis or allergic reaction
RareModerate

Possible in individuals with peptide sensitivity. Perform a patch test on a small area (e.g., inner arm) 24-48 hours before full application. Discontinue if rash, swelling, or itching develops.

Photosensitivity or increased UV sensitivity
RareModerate

Some depigmenting agents may increase photosensitivity. Use broad-spectrum SPF 30+ sunscreen daily during treatment. Avoid prolonged sun exposure.

Uneven depigmentation or patchy lightening
UncommonMild

May occur if application is inconsistent or uneven. Ensure thorough, uniform coverage of affected areas. Results typically appear after 4-8 weeks of consistent use.

Dosing Reference

ParameterValue
Dose range1-3 %
Frequency, timing and route - members only

Research disclaimer

Figures drawn from published research literature and community logs. Not clinical recommendations. Consult a qualified professional. Research use only.

Reconstitution Guide

Do not use saline or bacteriostatic saline, use only bacteriostatic water for reconstitution

Do not shake the vial vigorously; gentle swirling prevents peptide degradation

Discard immediately if the solution appears cloudy, discolored, or contains visible particles

Use within 30 days of reconstitution when stored at 2-8°C

Do not freeze the reconstituted solution; freezing may denature the peptide

Use the PeptideVolt reconstitution calculator for your exact concentration

Use the PeptideVolt reconstitution calculator for your exact concentration

Molecular and Pharmacological Data

Melanostatin DM inhibits melanin synthesis by suppressing tyrosinase enzyme activity, the rate-limiting enzyme in the melanin biosynthetic pathway. By reducing the conversion of L-tyrosine to dopaquinone, it decreases melanin production in melanocytes, leading to gradual skin brightening and reduction of hyperpigmentation. The peptide works through sustained inhibition rather than acute melanocyte destruction, supporting a gentle, reversible mechanism.

Pathways and mechanism detail available to members

Track your Melanostatin DM research

Free account. No credit card required.

Start Free

Browse the Research Library

40+ peptide profiles with mechanism summaries, dosing data, and reconstitution guides.

View all peptides

Research Use Only. All content on this page is provided for informational and educational purposes related to scientific research. Melanostatin DM is not approved for human use by the FDA or any equivalent regulatory body. This is not medical advice. Do not use any substance discussed here for therapeutic, diagnostic, or preventative purposes. Consult a qualified healthcare professional before making any health-related decisions. The Peptide Volt does not endorse the use of any research chemicals. 18+ only.